Overview PF-06372865 In Subjects With Chronic Low Back Pain Status: Completed Trial end date: 2015-08-01 Target enrollment: Participant gender: Summary PF-06372865 In Subjects With Chronic Low Back Pain Phase: Phase 2 Details Lead Sponsor: PfizerTreatments: NaproxenPF-06372865